קיורטן 10 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 10 mg - retinoids for treatment of acne - for the treatment of severe cystic acne that does not respond to other treatment.
קיורטן 40 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 40 mg - isotretinoin
קיורטן 5 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 5 mg - isotretinoin
קקסטון וטרינרי
euromar ltd - monensin as sodium - קפסולות - monensin as sodium 32.4 g
קקסטון וטרינרי
euromar ltd - monensin as sodium - קפסולות - monensin as sodium 32.4 g
קיורטן 30 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 30 mg - isotretinoin
קיורטן 30 מג
taro international ltd, israel - isotretinoin - קפסולות ג'לטין רכות - isotretinoin 30 mg - isotretinoin
סנדוסטטין 30 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
סנדוסטטין 20 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
סנדוסטטין 10 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 10 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.